Literature DB >> 18483933

Cross-reactive cellular immune responses in chickens vaccinated with live infectious bronchitis virus vaccine.

G D Raj1, R C Jones.   

Abstract

Two-week-old chickens were vaccinated intra-nasally with a live infectious bronchitis virus (IBV) vaccine (H120). On days 4, 7, 11 and 14 post-vaccination (p.v.) spleen mononuclear cells (MNC) prepared from control and vaccinated chickens were stimulated in vitro with homologous (strain M41) and heterologous (strains 7 and 793/B) virus antigens. Antigen-specific lymphoproliferation and interleukin-2 (IL-2) and interferon-y (IFN) production were used to measure cross-reactive cell mediated immune responses. In antigen-specific lymphoproliferation assays, it was found that while 4/16 vaccinated birds responded to the homologous antigen, only one responded to an heterologous antigen (strain 7). However, IL-2 production was seen in the supernatants of spleen MNC from vaccinated chickens stimulated with all three antigens. Production of IFN was also demonstrated in samples stimulated with the homologous and one heterologous (strain 7) antigen. Thus it appears that, following vaccination of chickens with live IBV vaccine, cross-reactive cellular immune responses occur that vary in magnitude with the strain of IBV used for in vitro stimulation.

Entities:  

Year:  1997        PMID: 18483933     DOI: 10.1080/03079459708419240

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  9 in total

1.  Mucosal, Cellular, and Humoral Immune Responses Induced by Different Live Infectious Bronchitis Virus Vaccination Regimes and Protection Conferred against Infectious Bronchitis Virus Q1 Strain.

Authors:  Rajesh Chhabra; Anne Forrester; Stephane Lemiere; Faez Awad; Julian Chantrey; Kannan Ganapathy
Journal:  Clin Vaccine Immunol       Date:  2015-07-22

2.  The effect of immunosuppression on protective immunity of turkey poults against infection with turkey coronavirus.

Authors:  Chien Chang Loa; Tsang Long Lin; Ching Ching Wu; Thomas Bryan; Tom Hooper; Donna Schrader
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2002-03       Impact factor: 2.268

Review 3.  Development and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a review.

Authors:  Gosse Bijlenga; Jane K A Cook; Jack Gelb; J J de Wit
Journal:  Avian Pathol       Date:  2004-12       Impact factor: 3.378

4.  Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine.

Authors:  Fang Yan; Yujun Zhao; Yongting Hu; Jianyang Qiu; Wenxin Lei; Wenhui Ji; Xuying Li; Qian Wu; Xiumin Shi; Zhong Li
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

5.  Oral immunization with a novel attenuated Salmonella Gallinarum encoding infectious bronchitis virus spike protein induces protective immune responses against fowl typhoid and infectious bronchitis in chickens.

Authors:  Irshad Ahmed Hajam; Jehyoung Kim; John Hwa Lee
Journal:  Vet Res       Date:  2018-09-12       Impact factor: 3.683

6.  Infectious bronchitis virus: Immunopathogenesis of infection in the chicken.

Authors:  G D Raj; R C Jones
Journal:  Avian Pathol       Date:  1997       Impact factor: 3.378

7.  Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccine by a bicistronic plasmid encoding nucleocapsid protein and interleukin-2.

Authors:  Mengjun Tang; Hongning Wang; Sheng Zhou; Guobao Tian
Journal:  J Virol Methods       Date:  2008-03-07       Impact factor: 2.014

8.  Specific antibody secreting cells from chickens can be detected by three days and memory B cells by three weeks post-infection with the avian respiratory coronavirus.

Authors:  Jianwu Pei; Ellen W Collisson
Journal:  Dev Comp Immunol       Date:  2005       Impact factor: 3.636

9.  The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV in chickens.

Authors:  Lang Tian; Hong-ning Wang; Dan Lu; Yun-fei Zhang; Ting Wang; Run-ming Kang
Journal:  Biochem Biophys Res Commun       Date:  2008-10-07       Impact factor: 3.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.